Wärnberg F - Search Results

1

Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.

Wärnberg F, Bergh J, Zack M, Holmberg L. Wärnberg F, et al. Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):495-9. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11352860

2

Prognosis in women with a carcinoma in situ of the breast: a population-based study in Sweden.

Wärnberg F, Bergh J, Holmberg L. Wärnberg F, et al. Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):769-74. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10498395

3

Ductal carcinoma in situ of the breast from a population-defined cohort: an evaluation of new histopathological classification systems.

Wärnberg F, Nordgren H, Bergh J, Holmberg L. Wärnberg F, et al. Eur J Cancer. 1999 May;35(5):714-20. doi: 10.1016/s0959-8049(99)00010-6. Eur J Cancer. 1999. PMID: 10505030

4

Risk of subsequent invasive breast cancer after breast carcinoma in situ.

Wärnberg F, Yuen J, Holmberg L. Wärnberg F, et al. Lancet. 2000 Feb 26;355(9205):724-5. doi: 10.1016/S0140-6736(99)03703-4. Lancet. 2000. PMID: 10703809

5

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.

Wärnberg F, Nordgren H, Bergkvist L, Holmberg L. Wärnberg F, et al. Br J Cancer. 2001 Sep 14;85(6):869-74. doi: 10.1054/bjoc.2001.1995. Br J Cancer. 2001. PMID: 11556839 Free PMC article.

6

Ductal carcinoma in situ of the breast: a new phenotype classification system and its relation to prognosis.

Wärnberg F, Casalini P, Nordgren H, Bergkvist L, Holmberg L, Ménard S. Wärnberg F, et al. Breast Cancer Res Treat. 2002 Jun;73(3):215-21. doi: 10.1023/a:1015816406078. Breast Cancer Res Treat. 2002. PMID: 12160327

7

Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosity.

Smeds J, Wärnberg F, Norberg T, Nordgren H, Holmberg L, Bergh J. Smeds J, et al. Among authors: warnberg f. Acta Oncol. 2005;44(1):41-9. doi: 10.1080/02841860410002842. Acta Oncol. 2005. PMID: 15848905

8

Quality aspects of the tissue microarray technique in a population-based cohort with ductal carcinoma in situ of the breast.

Wärnberg F, Amini RM, Goldman M, Jirström K. Wärnberg F, et al. Histopathology. 2008 Dec;53(6):642-9. doi: 10.1111/j.1365-2559.2008.03156.x. Histopathology. 2008. PMID: 19076680

9

Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution.

Zhou W, Muggerud AA, Vu P, Due EU, Sørlie T, Børresen-Dale AL, Wärnberg F, Langerød A. Zhou W, et al. Among authors: warnberg f. Mol Oncol. 2009 Jun;3(3):214-9. doi: 10.1016/j.molonc.2009.03.001. Epub 2009 Apr 2. Mol Oncol. 2009. PMID: 19403344 Free PMC article.

10

Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.

Niméus-Malmström E, Koliadi A, Ahlin C, Holmqvist M, Holmberg L, Amini RM, Jirström K, Wärnberg F, Blomqvist C, Fernö M, Fjällskog ML. Niméus-Malmström E, et al. Among authors: warnberg f. Int J Cancer. 2010 Aug 15;127(4):961-7. doi: 10.1002/ijc.25091. Int J Cancer. 2010. PMID: 19957331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters